Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -6.069\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) Cc1cc(C)c2nc(N)sc2c1
b.) Cc1ccsc1/C=N/Nc1ncnc2nc[nH]c12
c.) CCOc1ccc(S(=O)(=O)n2cnc(C)c2)cc1
d.) CCCCOc1ccc(CN2CCSCC2)cc1
e.) COc1cccc(/C=N/NC(=O)CSc2ccccc2C)c1O
Answer: e. COc1cccc(/C=N/NC(=O)CSc2ccccc2C)c1O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(/C=N/NC(=O)CSc2ccccc2C)c1O
COc1cccc(/C=N/NC(=O)CSc2ccccc2C)c1O
N-[(E)-(2-hydroxy-3-methoxyphenyl)methylideneamino]-2-(2-methylphenyl)sulfanylacetamide